ArticleJCO precision oncology2024

Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer.

Jonathan D Tward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.